- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01757704
Factors Responsible for the Effectiveness of the Lund De-airing Technique
Factors Responsible for the Effectiveness of the Lund Technique for De-airing Following Open Left Heart Surgery.
Study Overview
Status
Conditions
Detailed Description
Patients planned for open left heart surgery, mainly aortic valve replacement, will be included in the study. Patients with aortic valve replacement and concomitant coronary artery bypass with vein grafts only can also be included.
Exclusion criteria are; significant chronic obstructive pulmonary disease/emphysema, significant (>50%)carotid artery disease, need of concomitant internal mammary harvesting, prior cardiac or pulmonary surgery, pulmonary adhesions preventing pulmonary collapse, previous radiation to the chest and prior severe chest trauma. Intraoperative exclusion criteria are; failure to obtain adequate bilateral Trans-cranial Echo-Doppler signals from the medial cerebral arteries, finding of adherent pleurae and accidental opening of the pleurae.
Twenty patients will be randomized to two groups:
Group I: Intact pleura bilaterally, disconnection of the ventilator during cardiopulmonary bypass (CPB), followed by staged filling of the heart.
Group II: Open pleura bilaterally, disconnection of the ventilator during cardiopulmonary bypass to ensure bilateral pulmonary collapse followed by conventional filling of the heart.
Data will be compared to a third historical control group, consisting of ten patients with open pleurae with the ventilator disconnected followed by staged filling of the heart.
Primary outcomes:
- Duration of the de-airing procedure from the release of the aortic cross clamp to finished de-airing.
- Air microemboli to the brain registered on-line as gaseous microembolic signals on Trans-cranial Echo-Doppler (TCD). The sum of signals from the right and left middle cerebral artery are registered during the following time periods; from the release of the aortic cross clamp to start of cardiac ejection, from cardiac ejection to finished de-airing, and during ten minutes after finished de-airing.
- Magnitude of residual air emboli in the heart after finished de-airing as monitored by Trans-esophageal Echocardiography (TEE) with a Three-chamber view. The severity of residual air is classified in four grades after the appearance of visible air on TEE in left atrium (LA), left ventricle (LV) and aortic root (AO)as follows; Grade 0: no residual air, grade I: gas emboli detected in one of three anatomic areas during one cardiac cycle, grade II: gas emboli detected simultaneously in two of three anatomic areas during one cardiac cycle; grade III: gas emboli detected in all three anatomic areas during one cardiac cycle.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Skåne
-
Lund, Skåne, Sweden, 22350
- Lund University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients planned for aortic valve replacement with or without coronary vein bypass grafts
Exclusion Criteria:
- Significant chronic obstructive pulmonary disease and emphysema
- Previous history of thoracic or cardiac surgery
- Patients requiring internal mammary artery harvesting
- Unilateral or bilateral pulmonary adhesions to chest wall
- Previous radiation to the chest
Intraoperative Exclusion Criteria:
- Inability to obtain adequate bilateral Trans-cranial Echo-doppler signals
- Adherent pleurae
- Accidental opening of the pleurae
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Open pleurae & conventional filling of heart
In this group both pleurae will be opened and the ventilator disconnected during cardiopulmonary bypass to ensure bilateral pulmonary collapse.
However, after completion of the left heart procedure, the heart will be filled with blood actively from the heart-lung machine and manual de-airing performed in a conventional manner and de-airing monitored by intraoperative trans-esophageal echocardiography (TEE).
After de-airing is complete and patient has been weaned off the cardiopulmonary bypass the residual air in the left heart will be quantitatively assessed by TEE and Trans-cranial Echo-Doppler (TCD) over a period of 10 minutes.
|
After completion of the left heart surgery, the heart will be actively filled with blood from the cardiopulmonary bypass circuit and lungs fully ventilated with positive end-expiratory pressure to flush out all air trapped in the lung veins and left heart.
When there is no more visible air seen on Trans-esophageal echocardiography, the patient is weaned from cardiopulmonary bypass.
Other Names:
|
Experimental: Intact pleurae & staged filling of heart
In this group both pleurae will be left intact and the ventilator disconnected during cardiopulmonary bypass.
After completion of the left heart procedure, the heart will be filled with blood actively from the heart-lung machine in a staged manner after adequate cardiac contraction has been established.
De-airing will be obtained by active cardiac contraction and staged mechanical ventilation and de-airing monitored by intraoperative trans-esophageal echocardiography (TEE).
After de-airing is deemed complete and patient has been weaned off the cardiopulmonary bypass (CPB) the residual air in the left heart will be quantitatively assessed by TEE and Trans-cranial Echo-Doppler (TCD) over a period of 10 minutes.
|
After the end of the left heart surgery, the heart is gradually filled with blood from the cardiopulmonary bypass circuit.
Cardiac contractions fill the lungs with blood til no more air is seen in left heart on Trans-esophageal Echocardiography.
Thereafter the lungs are ventilated with 50% of the estimated lung minute volume and 5 cm positive end-expiratory pressure and cardiac filling and de-airing continued.
If no air is seen in the left heart full ventilation is started and the patient is weaned from cardiopulmonary bypass.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
Time Frame: Time from the release of the aortic crossclamp to cardiac ejection, an average of 10-15 minutes
|
Cerebral air emboli will be assessed quantitatively by On-line counting of gaseous microembolic signals (MES) by Trans-cranial Echo-Doppler (TCD) monitoring of the right and left middle cerebral artery.
The sum of the gaseous microembolic signals registered from the right and left middle cerebral artery will be reported.
|
Time from the release of the aortic crossclamp to cardiac ejection, an average of 10-15 minutes
|
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
Time Frame: Time from cardiac ejection to finished de-airing, an average of 5-10 minutes
|
Cerebral air emboli will be assessed quantitatively by On-line counting of gaseous microembolic signals (MES) by Trans-cranial Echo-Doppler (TCD) monitoring of the right and left middle cerebral artery.
The sum of the gaseous microembolic signals registered from the right and left middle cerebral artery will be reported.
|
Time from cardiac ejection to finished de-airing, an average of 5-10 minutes
|
Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery
Time Frame: Period of ten minutes after finished de-airing
|
Cerebral air emboli will be assessed quantitatively by On-line counting of gaseous microembolic signals (MES) by Trans-cranial Echo-Doppler (TCD) monitoring of the right and left middle cerebral artery.
The sum of the gaseous microembolic signals registered from the right and left middle cerebral artery will be reported.
|
Period of ten minutes after finished de-airing
|
Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
Time Frame: 0-3 minutes after finished de-airing
|
The severity of residual air emboli in three anatomic areas; left atrium, left ventricle and aortic root, is assessed by Trans-esophageal Echocardiography (TEE) and classified in grade 0-3 as follows, Grade o: no residual air; grade I: gas emboli detected in one of three anatomic areas during one cardiac cycle; grade II: gas emboli detected simultaneously in two of three anatomic areas during one cardiac cycle; grade III: gas emboli detected simultaneously in all three anatomic areas during one cardiac cycle.
|
0-3 minutes after finished de-airing
|
Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
Time Frame: 3-6 minutes after finished de-airing
|
The severity of residual air emboli in three anatomic areas; left atrium, left ventricle and aortic root, is assessed by Trans-esophageal Echocardiography (TEE) and classified in grade 0-3 as follows, Grade o: no residual air; grade I: gas emboli detected in one of three anatomic areas during one cardiac cycle; grade II: gas emboli detected simultaneously in two of three anatomic areas during one cardiac cycle; grade III: gas emboli detected simultaneously in all three anatomic areas during one cardiac cycle.
|
3-6 minutes after finished de-airing
|
Participants With <=Grade I Air Emboli as Assessed by Trans-esophageal Echocardiography (TEE) After Finished De-airing.
Time Frame: 6-10 minutes after finished de-airing
|
The severity of residual air emboli in three anatomic areas; left atrium, left ventricle and aortic root, is assessed by Trans-esophageal Echocardiography (TEE) and classified in grade 0-3 as follows, Grade o: no residual air; grade I: gas emboli detected in one of three anatomic areas during one cardiac cycle; grade II: gas emboli detected simultaneously in two of three anatomic areas during one cardiac cycle; grade III: gas emboli detected simultaneously in all three anatomic areas during one cardiac cycle.
|
6-10 minutes after finished de-airing
|
Duration of the De-airing Procedure
Time Frame: Time from release of aortic crossclamp to finished de-airing
|
The de-airing procedure is deemed completed when the Trans-esophageal Echocardiography (TEE) no longer visualizes air emboli in the heart Chambers.
The duration is likely to vary between individuals and reflects the complexity of the de-airing procedure.
|
Time from release of aortic crossclamp to finished de-airing
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Bansi Koul, MD, PhD, Cardiothoracic Surgery, Skåne University Hospital Lund, Sweden
Publications and helpful links
General Publications
- Al-Rashidi F, Blomquist S, Hoglund P, Meurling C, Roijer A, Koul B. A new de-airing technique that reduces systemic microemboli during open surgery: a prospective controlled study. J Thorac Cardiovasc Surg. 2009 Jul;138(1):157-62. doi: 10.1016/j.jtcvs.2009.02.037.
- Al-Rashidi F, Landenhed M, Blomquist S, Hoglund P, Karlsson PA, Pierre L, Koul B. Comparison of the effectiveness and safety of a new de-airing technique with a standardized carbon dioxide insufflation technique in open left heart surgery: a randomized clinical trial. J Thorac Cardiovasc Surg. 2011 May;141(5):1128-33. doi: 10.1016/j.jtcvs.2010.07.013. Epub 2010 Sep 3.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- BKML-003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Complication of Surgical Procedure
-
Hannover Medical SchoolKarolinska Institutet; Helsinki University Central Hospital; University of Leipzig and other collaboratorsRecruitingComplication of Surgical ProcedureGermany
-
Stanford UniversityActive, not recruitingComplication of Surgical ProcedureUnited States
-
Fundació Institut de Recerca de l'Hospital de la...UnknownComplication of Surgical ProcedureSpain
-
Zeyong YangUniversity of PennsylvaniaCompletedComplication of Surgical Procedure
-
Hannover Medical SchoolRecruitingComplication of Surgical ProcedureGermany
-
Hospital General Universitario ElcheDr. Negrin University HospitalCompletedCardiovascular Risk Factors of Medical and Septic Complications After Laparoscopic Bariatric SurgeryComplication of Surgical Procedure
-
Eske Kvanner AasvangCompletedComplication of Surgical Procedure | Respiratory Complication | Complication of Anesthesia | Circulatory; ComplicationsDenmark
-
KU LeuvenCompletedComplication of Surgical Procedure | Operation TimeBelgium
-
University of Rome Tor VergataCompletedComplication of Surgical Procedure | Leak; Blood
-
Richard PeruginiUniversity of Massachusetts, WorcesterRecruitingComplication of Surgical Procedure | Resident PhysiciansUnited States
Clinical Trials on Open pleurae & conventional filling of heart
-
Kocaeli UniversityCompleted
-
Meshalkin Research Institute of Pathology of CirculationUnknownAir Embolism | Neurological DamageRussian Federation
-
Sociedad Española de Neumología y Cirugía TorácicaCompletedRespiratory Disorder | Heart DisorderSpain
-
Hamilton Health Sciences CorporationThe Physicians' Services Incorporated FoundationUnknownAortic Aneurysm, AbdominalCanada
-
University of MichiganMott Children's Health CenterCompleted
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...CompletedSurgery | Hepatic Impairment | Cardiac Disease | Hyperbilirubinemia
-
Tanta UniversityCompleted
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...CompletedPostoperative Complications | Cardiopulmonary Bypass | Procalcitonin | Outcome | Lactate | C-reactive Protein | Open Heart Surgery
-
Assistance Publique - Hôpitaux de ParisTerminatedIncisional Hernia | Umbilical HerniaFrance